Log in
Enquire now
Genoskin

Genoskin

Provider of ex vivo human skin platforms for testing injectable drugs and implanted medical devices.

OverviewStructured DataIssuesContributors
Is a
Organization
Organization
Company
Company
B2X
B2B
B2B
CEO
Pascal Descargues
Pascal Descargues
CFO
‌
Frederick Roques
Company Operating Status
Active
COO
‌
Claire Jardet
Country
France
France
Crunchbase URL
crunchbase.com/organiz...genoskin
Date Incorporated
2011
Email Address
contact@genoskin.com
Facebook URL
@genoskin
Founded Date
January 1, 2011
Founder
Pascal Descargues
Pascal Descargues
Full Address
1, Place Pierre Potier 31100 Toulouse France
Headquarters
Toulouse
Toulouse
Industry
Engineering
Engineering
Consumer biotechnology
Consumer biotechnology
Biomedical engineering
Biomedical engineering
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Medical device
Medical device
Investors
‌
Caisse d'Epargne de Midi-Pyrenees
Bpifrance
Bpifrance
‌
OCCTE
‌
GSO Innovation
‌
Ca Toulouse 31
‌
Captech Sante
Crédit Agricole
Crédit Agricole
BNP Paribas
BNP Paribas
Latest Funding Round Date
September 16, 2025
Latest Funding Round Amount (USD)
8,700,000
Latest Funding Type
Series A
Series A
LinkedIn URL
@company/genoskin
Location
Toulouse
Toulouse
Number of Employees (Ranges)
11 – 50
Patents Assigned (Count)
1
Pitchbook URL
pitchbook.com/profiles...112918-42
Total Funding Amount (USD)
8,700,000
Twitter URL
@genoskin
Official Website
genoskin.com

Find more companies like Genoskin

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.